To estimate the trend in HT prevalence, treatment, and control in Romania, that has a crucial importance for the development of prevention strategies at national level, urgently needed in a very high CV risk SE European country.
Design and method:
A representative sample of 1970 Romanian adults (mean age 48.38 years, age range 18–80 years, 52.5%females, 70% response rate), were enrolled after signing written informed consent. The 2 study visits (Figure 1) took part in a special ’medical caravan’ entitled SEPHAR BUS.
HT was defined as study SBP >/= 140 mmHg and/or study DBP >/= 90 mmHg at both study visits or previously diagnosed HT treated in the last two weeks, regardless of BP values. BP control was defined as SBP < 140 mmHg and DBP < 90 mmHg in hypertensive subjects.
General HT prevalence is 45.1% (8.6% newly diagnosed HT, 53.8% awareness of HT), increasing with age (18–24 years – 15,4% vs. 25–34 years – 21.6% vs. 35–44 years – 34.6% vs. 45–54 years – 50.3% vs. 65–74 years – 62.6% vs. 65–74 years – 70% vs. >75years – 62.4%) regardless of the gender and area of residence. While majority (72.2%) of hypertensive subjects were treated (51.9% with >/= 2 drugs) only 30.8% of them had controlled BP values (general control rate 22.3%). Following the evolution from the last 10 years, it is expected that in 2020 the prevalence of HT will increase up to 44%, the awareness up to 96.2%, treatment of HT up to 91.2% and BP treatment control up to 36.6%.
Hypertension prevalence in Romania is increasing, although together with an increase in awareness, treatment and control. Possible explanations of this trend might be: unhealthy life-style and diet, increased salt-intake and increase in obesity and diabetes mellitus.
SEPHAR III survey represent a necessary step in HT management in our country offering an estimation of a real trend in HT prevalence, treatment, and control, trend that will serve as base for future prevention strategies, which are urgently needed in a very high CV risk SE European country.